The Bureau of Labor Statistics announced Monday that the highly anticipated January employment data will not be released as scheduled this Friday, citing disruptions from a partial federal government shutdown. The report will be published only after funding is restored.
Amid tightening climate regulations, Southern States LLC launches a new line of high-voltage switching products that replace the potent greenhouse gas SF6 with a readily available blend of carbon dioxide and oxygen, promising a dramatic reduction in environmental impact without compromising grid reliability.
Saudi Arabia unveils a new national strategy aiming to attract $64 billion in private investment by 2030 through over 220 public-private partnerships across key sectors, marking a significant shift in its economic model amid broader spending reassessments.
Amazon will discontinue its Amazon One palm-scanning payment and entry technology at retail locations in 2026, marking a retreat from one of its most ambitious physical commerce experiments.
For retirees facing Required Minimum Distributions (RMDs), converting a traditional IRA to a Roth can offer relief—but at a significant upfront tax cost. We analyze the long-term math and trade-offs for a 60-year-old with a $1.1 million portfolio, exploring whether staged conversions make financial sense.
As the 2026 Winter Olympics approach, the event is set to be the final one governed by a fragmented system of regulations for transgender athletes' participation. With the IOC poised to introduce universal guidelines, the Games in Italy spotlight a global debate balancing inclusion, fairness, and the future of women's sport.
A new report reveals a strategic pivot in recruitment for 2026, emphasizing targeted hiring amidst operational challenges and major workforce reductions at companies like Amazon.
As crypto prediction markets surge past $6B in weekly volume, a new phase of growth beckons. Driven by institutional interest, regulatory evolution, and AI integration, these platforms are poised to redefine speculative finance.
After months of political gridlock and a series of no-confidence votes, France's parliament is poised to adopt the contentious 2026 budget. The survival of Prime Minister Sebastien Lecornu's government hinges on Monday's vote, marking a critical juncture for the nation's fiscal and political stability.
Meta Platforms' relentless investment in artificial intelligence infrastructure is set to drive capital expenditures to unprecedented levels in 2026, raising questions about long-term returns for the cash-rich tech giant.
As the Federal Reserve prepares for a potential policy shift in 2026, analysts flag real estate, financials, energy, and consumer discretionary as vulnerable sectors. Structural challenges and changing macroeconomic conditions could pressure performance despite broader market gains.
As the 2026 tax filing deadline approaches, new and expanded federal tax credits and deductions offer significant opportunities for filers to reduce their liability or increase their refund. Experts warn that millions overlook these benefits annually.
With the FIFA World Cup in North America, the Milano Cortina Winter Olympics, and a packed calendar of major events, 2026 is poised to be a landmark year for sports. Brands and retailers are deploying sophisticated strategies that prioritize cultural marketing and community engagement over mere sales spikes, navigating a landscape where consumer loyalty is won through storytelling, not just sponsorship.
Morgan Stanley has upgraded Johnson & Johnson to 'Overweight,' raising its price target to $262, citing confidence in the healthcare giant's robust pipeline of new pharmaceuticals and medical devices.
As XRP hovers around $2, a stark divide emerges between institutional and algorithmic forecasts for its 2026 value. Standard Chartered's bullish $8 target contrasts with more cautious AI projections, with the outcome likely hinging on ETF inflows, regulatory clarity, and real-world adoption.
Analysts at Stifel have raised their price target for Nurix Therapeutics (NRIX) to $35, maintaining a Buy rating ahead of anticipated 2026 clinical milestones for its lead asset, bexobrutinib. The move comes as Wells Fargo also adjusted its target, highlighting divergent near-term views but shared long-term optimism for the biotech firm.
The $12 trillion asset manager founded by Jack Bogle announced another round of expense reductions across 53 funds, saving investors an estimated $600 million over two years and reinforcing its half-century mission of driving down costs for the everyday investor.
Realty Income, the 'Monthly Dividend Company,' has now made over 650 consecutive monthly payments to shareholders. While its financials show a robust cushion, rising interest rates and a shifting retail landscape pose questions about the sustainability of its legendary income stream.
Twist Bioscience kicks off fiscal 2026 with robust growth, reporting a 17% year-over-year revenue increase to $103.7 million. The company credits its semiconductor-based DNA synthesis platform and surging demand from AI-enabled drug discovery programs as key drivers, while reiterating its path to adjusted EBITDA breakeven within the year.
Investors who held shares in SouthGobi Resources Ltd. (CVE:SGQ) since 2019 have seen a staggering 486% return, a powerful case study in long-term equity investing despite recent volatility.
